コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 medical record review) and prospectively at hospital discharge.
2 Overall, 30.4% patients survived to hospital discharge.
3 fect of independent variables on survival to hospital discharge.
4 s associated with AF within 90 days of index hospital discharge.
5 nce Category score of 1 or 2, at the time of hospital discharge.
6 and risk of 90-day all-cause mortality after hospital discharge.
7 y outcome was favorable neurologic status at hospital discharge.
8 eceding SCA and association with survival to hospital discharge.
9 ive impairment lasting at least 1 year after hospital discharge.
10 48, and 72 hours after injury, as well as at hospital discharge.
11 ated with likelihood of favorable outcome at hospital discharge.
12 pairment that persists months to years after hospital discharge.
13 primary outcome of interest was survival-to-hospital discharge.
14 ks, 2 to 6 weeks, or more than 6 weeks after hospital discharge.
15 in at least 1 CR session within 6 months of hospital discharge.
16 lation, survival, and neurologic outcomes at hospital discharge.
17 hospital discharge and functional outcome at hospital discharge.
18 equire early readmission after their initial hospital discharge.
19 amedic OHCA exposure and patient survival to hospital discharge.
20 easures: The primary outcome was survival to hospital discharge.
21 ion and neurologically favorable survival to hospital discharge.
22 hing placebo twice daily for 7 days or until hospital discharge.
23 es throughout pregnancy and occurring before hospital discharge.
24 ed serum creatinine >/=200% from baseline at hospital discharge.
25 on was associated with decreased survival to hospital discharge.
26 ardiac arrest is associated with survival to hospital discharge.
27 r death by suicide after medical or surgical hospital discharge.
28 of acute respiratory failure survivors after hospital discharge.
29 All other infants receive HepB before hospital discharge.
30 23.7%, and 21.0%, respectively, survived to hospital discharge.
31 imary outcome was any stroke or death before hospital discharge.
32 they arrived in the inpatient ward and until hospital discharge.
33 e with invasive devices or chronic wounds at hospital discharge.
34 ation, including mortality, occurring before hospital discharge.
35 roduced no trend toward improved outcomes at hospital discharge.
36 -acquired infections and lower likelihood of hospital discharge.
37 days covered (PDC) during 180 days following hospital discharge.
38 B, and D; presented with MI; and survived to hospital discharge.
39 nfirmed coronary artery disease surviving to hospital discharge.
40 l of 104 patients (25.0%) did not survive to hospital discharge.
41 ssion from 2006 through 2009 and survived to hospital discharge.
42 eased functional independence of patients at hospital discharge.
43 rebrovascular outcomes through 2 years after hospital discharge.
44 during the initial recovery period following hospital discharge.
45 Recovery was defined as reversal at hospital discharge.
46 effectiveness measure was survival status at hospital discharge.
47 nd improved patients' functional mobility at hospital discharge.
48 ng home/long-term/rehabilitation facility on hospital discharge.
49 did not appear to affect overall survival to hospital discharge.
50 g the 1558 patients, 487 (31.3%) survived to hospital discharge.
51 after opioids were discontinued, 28 days, or hospital discharge.
52 ke, or acute renal failure up to the time of hospital discharge.
53 I in 2007-2009 and survived for 1 year after hospital discharge.
54 culation was restored in 34%; 9% survived to hospital discharge.
55 psychiatric disorders in the 12 months after hospital discharge.
56 d for 24 hours, and 4488 (36.2%) survived to hospital discharge.
57 Primary outcome was survival to hospital discharge.
58 male, and 24256 patients (22.4%) survived to hospital discharge.
59 sociated with better neurological outcome at hospital discharge.
60 rmine both the cause and time to death after hospital discharge.
61 ical research evaluating ARF survivors after hospital discharge.
62 morbidity was associated with longer time to hospital discharge.
63 The primary outcome is diagnosis of HO at hospital discharge.
64 ng acute respiratory failure survivors after hospital discharge.
65 comes are associated with recovery status at hospital discharge.
66 increased risk of cognitive impairment after hospital discharge.
67 patients, a total of 586 (9.7%) died before hospital discharge.
68 iately before LT and weekly thereafter until hospital discharge.
69 swallowing examinations and follow-up until hospital discharge.
70 ch 60.4% (n = 58/96) remained positive until hospital discharge.
71 or in-hospital adverse events but also after hospital discharge.
72 The primary outcome was survival to hospital discharge.
73 e, was associated with decreased survival to hospital discharge.
74 In the 182 days after myocardial infarction hospital discharge, 15.4% of beneficiaries discontinued
75 age, 32 [6] years), 58 (67%) survived until hospital discharge (17 born at 22 weeks and 41 born at 2
78 orhoods had lower adjusted survival rates to hospital discharge (25%-50% black: odds ratio, 0.76; 95%
79 e readmissions because of previous premature hospital discharge, 32 (19%) because of problems that co
82 tation, results in high rates of survival-to-hospital discharge (45%) and favorable neurologic outcom
84 Of 7,656 ICU patients, 5,259 survived to hospital discharge (5,215 [99.2%] matched to hospital co
86 chronic dialysis dependency were assessed at hospital discharge according to the quintile (Q) of age.
88 Conclusions and Relevance: After psychiatric hospital discharge, adults with complex psychopathologic
89 gher survival rates: 66% (29/44) survived to hospital discharge after 1-3 minutes of cardiopulmonary
92 death (HR, 0.82 [95% CI, .55-1.22]), time to hospital discharge alive (HR, 1.07 [95% CI, .91-1.26]),
93 bation alive vs ventilator death and time to hospital discharge alive vs hospital death using competi
97 verall Performance Category were rescored at hospital discharges; all three were scored at 3 and 12 m
98 hospital and many did not need opioids after hospital discharge, although approximately 50% of patien
99 data, we assessed AHM use within 90 days of hospital discharge among HF patients with diabetes melli
100 observation-service use within 30 days after hospital discharge among Medicare elderly beneficiaries
101 1-mg dose of epinephrine), survival rate at hospital discharge among patients meeting these criteria
102 ng from acute lung injury (ALI) diagnosis to hospital discharge, an interval that, to our knowledge,
103 ative pulmonary complications computed until hospital discharge, analyzed with a common odds ratio (O
105 19,804), 10,931 patients (3.42%) died before hospital discharge and 669 patients (0.18%) died after e
106 iated with a lower likelihood of survival to hospital discharge and a lower likelihood of favorable n
109 iac arrest resuscitation, function scores at hospital discharge and at 3 months predicted 12-month pe
111 hree cohorts were ascertained from the state hospital discharge and death registries; subsequent canc
113 le to health care professionals for the safe hospital discharge and home management of these complex
118 CPR was associated with improved survival to hospital discharge and survival with favorable neurologi
120 iated with greater likelihood of survival to hospital discharge and survival with favorable neurologi
122 or each study group during the 90 days after hospital discharge and the demographically matched US ge
124 Overall, seven patients (19%) survived to hospital discharge and were alive and in remission of th
125 Among older patients with MI who survived to hospital discharge and were not discharged to hospice, t
126 trast, patients who returned to the ED after hospital discharge and were readmitted had higher rates
127 s were identified through pathology reports, hospital discharges and copayment exemptions and matched
130 ained return of circulation, 45% survived to hospital discharge, and 89% of survivors had favorable n
131 .4%) achieved ROSC, 1232 (10.8%) survived to hospital discharge, and 905 (8.0%) had an mRS score of 0
132 ry end points included survival at 24 hours, hospital discharge, and favorable neurologic outcome at
134 The primary outcome measure was survival to hospital discharge, and secondary outcomes included retu
135 rovision and timeliness of TCPR, survival to hospital discharge, and survival with favorable function
136 in patients with OHCA does not persist after hospital discharge, and they support efforts to improve
137 s associated with a reduction in survival to hospital discharge (AOR, 0.71; 95% CI, 0.55-0.92; P=0.00
138 on multiple sources (neurologic departments, hospital discharge archives, and mortality records).
139 sequently have elevated rates of death after hospital discharge as a result of secondary organ damage
140 categorized cause of death in the year after hospital discharge as cardiovascular, cancer, infection-
141 espiratory failure survivors' outcomes after hospital discharge, as related to the 19 preliminary out
142 aparin once-daily dosing, early ambulation), hospital discharge before initial trough levels could be
144 interest was functional status determined at hospital discharge by a licensed physical therapist and
147 t linking AMA Physician Masterfile data with hospital discharge claims from Florida and New York (200
148 ination Survey, as determined from the final hospital discharge codes (International Classification o
150 ation (adjudicated using electrocardiograms, hospital discharge codes, and death certificates), strok
151 apeutic hypothermia during CPR were alive at hospital discharge compared with 11.4% who received stan
152 the shortest procedure duration and time-to-hospital discharge compared with the other techniques (P
155 n the SRT group received daily therapy until hospital discharge, consisting of passive range of motio
157 ction (AMI) and stroke outcomes, we analyzed hospital discharge data from the Nationwide Inpatient Sa
160 retrospective cohort study using a statewide hospital discharge database identified all patients admi
163 s of centrality calculated from a state-wide hospital discharge dataset to predict facility-level CRE
164 unadjusted infant-level rate of death before hospital discharge decreased from 14.0% in 2005 to 10.9%
165 are morbidity and mortality one month after hospital discharge, defined by the Clavien- Dindo classi
166 The large number of survivors and the use of hospital discharge diagnoses made it possible to draw a
167 tionnaire on psoriasis was validated against hospital discharge diagnoses of psoriasis and compared w
168 rge diagnoses of psoriasis and compared with hospital discharge diagnoses of type 2 diabetes mellitus
169 mortality outcomes of depression (defined by hospital discharge diagnoses or antidepressant medicatio
170 ained using clinic visit electrocardiograms, hospital discharge diagnosis codes, death certificates,
171 electrocardiogram at ARIC follow-up visits, hospital discharge diagnosis, or death certificates thro
172 patients with HF who died within 6 months of hospital discharge did not receive a discharge hospice r
173 xis from Jan 1, 2004, to March 31, 2013, and hospital discharge episode statistics for patients with
175 s the extent to which breastfeeding prior to hospital discharge explained the racial disparity in inf
176 ere identified using Medicare and California hospital discharge files (1993-2012) and self-completed
177 other causes of death) up to 10 years after hospital discharge following adversity-related (self-inf
178 ients (aOR, 1.08; 95% CI, 0.71-1.63), and at hospital discharge for 10 (2.5%) vs 5 (1.3%) patients (a
179 nitiation among Medicare beneficiaries after hospital discharge for a myocardial infarction may help
180 he risk for suicide during the 90 days after hospital discharge for adults with first-listed diagnose
182 ublications reporting patient outcomes after hospital discharge for ICU survivors have grown from 3 i
183 offending (primary outcome) within 1 year of hospital discharge for inpatients or clinical contact wi
184 rends in high-intensity statin use following hospital discharge for MI were analyzed among patients 1
185 first statin prescriptions filled following hospital discharge for MI were for high-intensity doses
186 ctors of high-intensity statin use following hospital discharge for myocardial infarction (MI) betwee
187 ith a statin fill claim within 30 days after hospital discharge for myocardial infarction in 2007 to
189 ization Project of 14 states to evaluate all hospital discharges for patients aged 0 to 17 years (her
192 We performed a retrospective cohort study of hospital discharges from October 20, 2015, to October 19
196 tory failure (ARF) survivors' outcomes after hospital discharge has substantial heterogeneity in term
197 ation was not associated with survival after hospital discharge (hazard ratio, 0.99; 95% CI, 0.76-1.2
199 nce: Multiple clinical features available at hospital discharge identified a cohort of individuals at
200 lt general ICUs during 2005 and surviving to hospital discharge, identified from the Scottish Intensi
202 were significantly more likely to survive to hospital discharge if they received bystander-initiated
203 observational studies reporting survival to hospital discharge in OHCA patients where an automated e
204 and complexity of CAD and report survival to hospital discharge in patients experiencing refractory V
206 the association between functional status at hospital discharge in survivors of critical care and ris
208 intensively followed from PICU admission to hospital discharge in the Collaborative Pediatric Critic
209 was common in ICU patients, sustained until hospital discharge in the majority of affected patients,
212 spective analysis of 2,423,031 US acute care hospital discharges in 2012 for patients ages 0 to 21 ye
213 -a composite of vital sign stabilisation and hospital discharge-in the influenza-positive population.
215 this regulation, as the incidence of pain at hospital discharge is greater than 95%, and opioids are
216 Their risk of death in the decade after hospital discharge is twice as high as that of adolescen
217 ts by use of general practitioners' records, hospital discharge letters, pharmacy dispensing data, an
218 increased risk for suicide immediately after hospital discharge, little is known about the extent to
220 existing morbidity and functional ability at hospital discharge may be important determinants of long
221 0.0054), and improved functional mobility at hospital discharge (mmFIM score 8 [4-8] in intervention
222 days of physical therapy treatment prior to hospital discharge (n = 2,293), the adjusted odds of 90-
223 ovir or oral valganciclovir once daily until hospital discharge (n = 84) or to receive matching place
226 eases in high-intensity statin use following hospital discharge occurred over this period among patie
227 1-year survival and readmission rates after hospital discharge of older MI survivors with and withou
229 ectional analysis evaluated Medicaid-insured hospital discharges of patients 20 years and younger fro
231 or new-onset renal failure with dialysis by hospital discharge or by day 28, whichever came first.
232 ry, and mortality recorded at 7 days, and at hospital discharge or death, whichever came earlier.
234 The absence of anticoagulation therapy at hospital discharge (p = 0.002), a valve-in-valve (TAVR i
237 r equal to 70, we evaluated relationships of hospital discharge Pediatric Cerebral Performance Catego
240 ociated with the number of organ failures as hospital discharge rates were 69%, 50%, 42%, and 0% amon
241 onally representative sample of US pediatric hospital discharge records collected every 3 years from
242 rvational study, we used routinely collected hospital discharge records from English National Health
247 after baseline, and by record linkage to the hospital discharge registry and the reimbursement regist
249 vivors were rehospitalized within 30 days of hospital discharge; rehospitalized patients had high rat
251 al regurgitation, which were identified from hospital discharge reports or primary care records.
253 ociated with decreased chance of survival to hospital discharge, ROSC, 24-hour survival, and survival
254 Scheduled early follow-up at the time of hospital discharge rose from 51% to 65% over time (P<0.0
255 The primary outcome measure was survival at hospital discharge; secondary end points included return
256 to cover the costs of study medication after hospital discharge, some patients decided to switch to c
258 uiring hospitalization using the US National Hospital Discharge Survey (1970-2010) and five disease g
263 ative incidence of each outcome studied from hospital discharge through 2 years with log-rank tests a
266 Council sum score, >/= 48 vs < 48) and with hospital discharge to home (vs healthcare facility).
267 itive women, and HepB is administered before hospital discharge to infants of HBsAg-negative women.
269 d for a COPD exacerbation were randomized at hospital discharge to receive either (1) motivational in
270 protein levels (>2 mg/L), within 14 days of hospital discharge, to daily subcutaneous injections wit
271 Infants received follow-up until 90 days, hospital discharge, transfer to a non-study-affiliated h
272 int being diagnosis of a new pressure ulcer, hospital discharge/transfer or 28days; whichever occurre
273 llow-up time was calculated as the time from hospital discharge until the earliest among death with L
274 o the first outpatient follow-up visit after hospital discharge was 14 days (interquartile range, 7-2
276 the lowest quartile of functional status at hospital discharge was associated with an increased odds
277 igh statin adherence over the year following hospital discharge was defined as proportion of days cov
280 nders, we found that the rate of survival to hospital discharge was lower during nights than during d
283 -recommended initiation of H-ISDN therapy at hospital discharge was uncommon, and adherence was low.
286 rd ratios (ARHs) of short-term suicide after hospital discharge were also estimated by Cox proportion
290 d as an increase of >/= 3 from preillness to hospital discharge) were 4.6% (site range, 2.6-7.7%) and
291 ts were major bleeding within 48 h or before hospital discharge (whichever occurred first) and 30-day
293 rge, ROSC, 24-hour survival, and survival to hospital discharge with a favorable neurological outcome
294 .4% vs 0.8%, p <0.001), but survival rate to hospital discharge with favorable neurologic outcome was
297 survivors returned to work by 13 weeks after hospital discharge, with 68% ever returning by 12 months
298 A total of 75% of VTE events occurred after hospital discharge, with a 19.5-day median time to VTE.
299 rgoing PCI from 2004 to 2007 who survived to hospital discharge without a bleeding event were identif
300 Among 8137 post-PCI patients surviving to hospital discharge without in-hospital bleeding, 391 (4.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。